Eli Lilly Cuts Zepbound Prices, Boosting Access
Update: 2025-12-01
Description
Eli Lilly reduces Zepbound prices by up to $100, aiming to improve access to weight-loss medication. Novo Nordisk follows suit with price cuts for Wegovy and Ozempic. Despite high initial costs and limited coverage, more employers are adding GLP-1 weight-loss medications to their plans.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
